Clinical Trials Browser

Phase NA × Cholangiocarcinoma × Blood Culture × Clear all

NCT01673269 2017-05-17

Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

Phase NA Completed

Gastrointestinal

Cholangiocarcinoma, Choledocholithiasis